ArticleCNS & neurological disorders drug targets2017

Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.

Mohammad A Kamal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.